Vektor Medical is on a mission to revolutionize arrhythmia care. The FDA-cleared vMap technology, is an AI-based arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.
Vektor Medical, Inc.的外部链接
LIVE NOW ???? Join 'The Importance of Trigger Mapping in AF and VT.' https://ow.ly/LGwk50U9jyp
LIVE NOW ???? Join Devi Nair at 19:30 CET for a case and an expert discussion on 'The Importance of Trigger Mapping in AF and VT.' https://ow.ly/LGwk50U9jyp Chair: Devi Nair (Jonesboro, US) Case Operators: Anish Amin (Columbus, US); Benjamin D’Souza (Philadelphia, US) #RIOCongress2024
?? Reminder ???Tomorrow at 1:30 PM ET / 6:30 PM UTC ?? Join the Rhythm Interventions Online 2024 CME-accredited session: "The Importance of Trigger Mapping in AF and VT." Speakers: ? Dr. Devi G Nair, MD, FACC, FHRS ? Dr. Atul Verma ? Dr. Ben D’Souza ? Dr. Anish Amin Gain actionable insights to improve, enhance, and accelerate ablation outcomes. Experience live vMap-guided cases and participate in a Q&A. ???Register?now?https://lnkd.in/gWtcQt9Y #RIOcongress2024 #CardioEd #CME #AFib #VT #epeeps
vMap fits into the existing workflow in your EP lab to streamline the mapping process, automate tasks, and provide support in identifying arrhythmic beats to improve efficiency, and increase confidence in decision-making. https://lnkd.in/g5h3xAzm #cardiology #ai #medtech
Today, we announced data demonstrating?vMap’s ability to achieve?91.1% accuracy?in distinguishing epicardial from endocardial ventricular tachycardia—far surpassing the 62.5% accuracy of traditional visual ECG analysis. Click below ?? to learn more about the data?and presentation details and to share your thoughts on the news.
#AHA24 #News We are proud to share that new data on?vMap, our AI-powered solution for non-invasive arrhythmia analysis and localization, will be presented at the?American Heart Association (AHA) Scientific Sessions 2024?in Chicago. The data demonstrates?vMap’s ability to achieve?91.1% accuracy?in distinguishing epicardial from endocardial ventricular tachycardia—far surpassing the 62.5% accuracy of traditional visual ECG analysis. This represents a significant step in improving precision and outcomes in cardiac arrhythmia treatment. We invite you to join us at the AHA session to explore how vMap is redefining the future of cardiac care. ???When:?Sunday, November 17, 11:30 a.m. ???Where:?AHA Scientific Sessions 2024, Chicago Additional details are available in today's press release: https://lnkd.in/gfxPnRKW #HealthcareInnovation #AIinMedicine #Arrhythmia #Cardiology
??Rhythm Interventions Online 2024 is happening next week! Mark your calendar for Thursday, Nov. 21, to join the “The Importance of Trigger Mapping in AF and VT” session featuring Dr. Devi G Nair, MD, FACC, FHRS, Dr. Atul Verma, Dr. Ben D’Souza, and Dr. Anish Amin. Session Highlights: ??Discover how vMap can improve, enhance, & accelerate ablation procedures ? Experience live vMap-guided case presentations ?? Engage in a Q&A session with the experts Don't miss this opportunity for free access to accredited CME learning ?? https://lnkd.in/gWtcQt9Y #RIOcongress2024 #epeeps #CardioEd #CME #cardiology #electrophysiology?#ai #healthcare
Cardiac arrhythmias are key drivers for three global health crises — cardiac death, stroke, and dementia. “It’s extremely difficult to understand a cardiac arrhythmia and the precise location of its source.” vMap is changing this. “We’re able to successfully and non-invasively understand the origins of a patient’s arrhythmia.” vMap’s AI-based technology changes cardiac care by improving patient outcomes and enhancing operational efficiency.” Hear more from Vektor CEO Robert J. Krummen during his recent presentation at #LSIEurope24. LSI #medtech #innovation #vMap
Empowering electrophysiologists to navigate complex cardiac structures with accuracy and confidence. That is how we are creating meaningful change. https://lnkd.in/gS-ARD2t #medtech #cardiology #epeeps #innovation
???This is how physicians can deliver ablative energy and know it is a very effective and highly successful procedure.?? Learn from Dr. Gery Tomassoni as he shares his experience using #vMap in today's ?????????????????? ?????????????? segment. #medtech #epeeps #cardiology #ai
Tuesday at #BIOEurope2024, Vektor co-founder Dr. David Krummen will participate in the panel discussion “Why Did It Have to Be Me?”: AI for Diagnosis, hosted by TVM Capital Life Science. The session will explore how #AI is reshaping #biopharma as panel participants discuss the latest developments, challenges, and future prospects in leveraging AI for diagnostic purposes. Details: https://lnkd.in/eqyKyNr8 #medtech #innovation